Draximage Mdp: Affected Lot May Contain Particulate Matter
DRAXIMAGE MDP, a medication distributed across Canada, is being recalled because some affected lots may contain particulate matter that shouldn't be present in the product. This is a Class I recall, which means the product could cause serious harm. The recall applies to specific lots of DRAXIMAGE MDP distributed throughout Canada.
- Product
- DRAXIMAGE MDP
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2022-08-30
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/8db46c4f-3862-4030-93e9-3d97ef74770a